tirzepatide and depression New weight-loss drugs linked to lower risk of depression: study Can Tirzepatide Cause Depression?

Hughes, PA-C

All clinicians we work with are U.S.-based and board-certified

Preparing injectable tirzepatide Brand-name tirzepatide (Mounjaro, Zepbound) comes in pre-filled injection pens

Types and risk factors Understanding gallstone types helps predict risk and management strategies: How Mounjaro affects gallbladder function Clinical trial data on gallbladder events The SURMOUNT clinical trials provide comprehensive safety data on Mounjaros gallbladder effects 1 : SURMOUNT-1 findings: Gallbladder-related adverse events: 0.6% (Mounjaro) vs 0% (placebo) Most events were cholelithiasis (gallstones) or cholecystitis Higher doses (10 mg, 15 mg) showed a slightly higher risk than 5 mg Most events occurred within the first 20 weeks of treatment Severity of events: Mild to moderate: 85% of cases Severe: 15% of cases Led to treatment discontinuation: 2 cm) Porcelain gallbladder Concurrent liver disease Pre-treatment screening NICE guidelines dont mandate gallbladder screening before starting GLP-1 medications 5 , but consider assessment if: High-risk patients: Previous gallstone symptoms Multiple risk factors present Strong family history Previous rapid weight loss attempts Screening options: Detailed history and examination Liver function tests (may be elevated with gallstones) Ultrasound scan if clinically indicated Risk stratification *Monitoring frequency represents expert practice suggestions rather than mandated protocol

After each injection, record the date, the number of units drawn, the vial concentration, the resulting milligram dose, and any side effects you notice over the following 48-72 hours

Whether a synchronous consultation is required in your specific state will depend on your location and the clinician's determination